Plain-English translation of NCT05679674 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a combination of two treatments for locally advanced pancreatic cancer: a specialized form of radiation therapy called stereotactic ablative body radiation therapy (SABR), plus a wearable device called tumor treating fields (TTF) that delivers mild electric currents to the tumor area. You would receive the radiation once daily for five days, and wear the electric field device for at least 18 hours each day starting on day one of radiation and continuing as long as the treatment is helping.
Pancreatic cancer that hasn't spread beyond the local area is very hard to treat, and current standard therapies don't work well enough for many patients. Researchers believe that combining focused radiation with the electric field device might work better together to slow or stop tumor growth.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital or radiation center once per day for five consecutive days to receive the focused radiation treatment. At the same time, you would begin using the electric field device, wearing it under your clothing for at least 18 hours each day. You would continue wearing the device every day until your cancer progresses or side effects become too severe. Throughout the trial, you'll have regular check-ups, blood tests, and imaging scans to monitor how well the treatment is working and how you're tolerating it.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States